COMMUNIQUÉS West-GlobeNewswire

Philips showcases unique augmented reality concept for image-guided minimally invasive therapies developed with Microsoft
24/02/2019
February 24, 2019 Companies collaborate to combine Philips’ industry-leading Azurion image-guided therapy platform with Microsoft HoloLens 2 mixed reality computing platform as a concept for the operating room of the [...]
BioCryst Reports ZENITH-1 Results With Oral BCX7353 Which Confirm Rapid Onset of Action, Sustained Activity and Robust Dose Response for Treatment of Acute HAE Attacks
23/02/2019
— Based on ZENITH-1 data, company plans to commence Phase 3 trial of single-dose 750 mg oral BCX7353 for acute treatment of hereditary angioedema (HAE) attacks in summer 2019— —Data show excellent clinical dose response [...]
FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results
23/02/2019
SAN FRANCISCO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today announced that it will [...]
SHDS Informs Individuals of Security Incident Affecting Subset of Patients of East Los Angeles Doctors Hospital and Other Customers
23/02/2019
SAN DIEGO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Sharecare Health Data Services (“SHDS”), formerly known as BACTES Imaging Solutions, announced today that some personal information, including protected health information, [...]
Fluidigm to Participate in Upcoming Investor Conferences
22/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced [...]
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22/02/2019
BOTHELL, Wash., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
OrthoPediatrics Corp. Honored as One of the Best Place to Work in Indiana for a Third Year
22/02/2019
WARSAW, Ind., Feb. 22, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named as [...]
priMED Medical Products Named 2019 Alberta’s Top Employer
22/02/2019
Corporate culture, working environment, employee health, and social responsibility cited as key factors in winning the award EDMONTON, Alberta, Feb. 22, 2019 (GLOBE NEWSWIRE) -- After a banner year in 2018, priMED [...]
Canaccord Genuity initiates research coverage of CLS Holdings
22/02/2019
LAS VEGAS, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Canaccord Genuity, the largest independent investment dealer in Canada, has initiated research coverage of CLS Holdings USA Inc. (OTCQB:CLSH). The initiation report is 38 [...]
Constellation Pharmaceuticals to Present at Upcoming Investor Conferences
22/02/2019
CAMBRIDGE, Mass., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Notice Convening the Annual General Meeting
22/02/2019
February 22, 2019 Announcement no. 3 NOTICE CONVENING THE ANNUAL GENERAL MEETING The Board of Directors hereby convenes the Annual General Meeting of BioPorto A / S (the “Company”): March 18, 2019, at 3.00 pm (CET), At [...]
Aura Health Provides Further Clarity Regarding Offering and Strategic Investor
22/02/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Feb. 22, 2019 ( [...]
DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association
22/02/2019
Montrouge, France, February 22, 2019 DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical [...]
DBV Technologies annonce la publication des résultats détaillés de l’essai clinique de phase III évaluant Viaskin Peanut comme un nouveau traitement de l’allergie à l’arachide dans le Journal of the American Medical Association
22/02/2019
Montrouge, France, le 22 février (17 : 00 CET) 2019 DBV Technologies annonce la publication des résultats détaillés de l’essai clinique de phase III évaluant Viaskin Peanut comme un nouveau traitement de l’allergie à l’ [...]
Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer
22/02/2019
Management Plans to Hold a Conference Call on March 4, 2019 to Provide an Operational and Clinical Update RALEIGH, N.C., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals , Inc. (Nasdaq: INNT), a clinical [...]
Veritas Enrolls First Patient in Clinical Study to Assess Pain Control with Lead Product
22/02/2019
SAN JUAN, Puerto Rico, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico LLC, a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), today announced the [...]
Coherus BioSciences Announces New Employment Inducement Grants
22/02/2019
REDWOOD CITY, Calif., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective February 21, 2019, the compensation committee of the company’s board of directors granted [...]
Merit Medical to Participate at Six Upcoming Conferences
22/02/2019
SOUTH JORDAN, Utah, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Diversicare to Announce Fourth Quarter 2018 Financial Results on Thursday, February 28, 2019
22/02/2019
BRENTWOOD, Tenn., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its fourth quarter ended December 31, 2018, on [...]

Pages